Evaluate the Role of Klebsiella pneumoniae in an Animal Model for Systemic Analysis of Serum Interleukin [IL-6, IL-18 and IL-23] and Chemokines [CCL-5 and CCL-11]
Abstract
Klebsiella pneumoniae is an important opportunistic pathogen associated with implant-related and healthcare-associated infections, where early diagnosis is essential for effective treatment. This study investigated the volatile organic compounds (VOCs) produced by carbapenem-susceptible and carbapenem-resistant K. pneumoniae and evaluated the associated inflammatory response in a murine model of implant-associated infection. Bacterial VOCs were identified using gas chromatography–mass spectrometry (GC–MS), and their dynamic production was monitored over 24 h. A subcutaneous mouse infection model was established to determine serum levels of IL-6, IL-18, IL-23, CCL-5, and CCL-11 using multiplex immunoassays. GC–MS analysis identified several characteristic VOCs, including 2-heptanone, 2-pentene, 3-methylbutanal, benzaldehyde, 3-methylbutyl acetate, methacrolein, mercaptoacetone, and 2-phenylfuran, with three distinct release patterns observed during bacterial growth. Mice with bacteria-implant infections exhibited significantly higher serum concentrations of IL-6, IL-18, IL-23, CCL-5, and CCL-11 than animals with sterile implants or bacterial infection alone (P < 0.05), indicating a pronounced inflammatory response associated with bacterial colonization of implants. These findings demonstrate that VOC profiling, combined with inflammatory cytokine and chemokine analysis, provides valuable biomarkers for the early diagnosis and monitoring of K. pneumoniae implant-associated infections and may contribute to improved clinical management and therapeutic intervention.
Full text article
References
Roach, D. J. (2024). Clinical and Genomic Characterization of a Cohort of Patients With Klebsiella pneumoniae Bloodstream Infection. Clin. Infect. Dis. 78 (1), 31–39.
Tacconelli, E. (2018). Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18 (3), 318–327.
Wang, M. (2022). Multi-Drug Resistant Organism Network I. Clinical outcomes and bacterial characteristics of carbapenemresistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. Lancet Infect. Dis. 22 (3), 401–412.
Hu, F. (2018). Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Clin. Microbiol. 38 (12), 2275–2281.
Jin, Z. (2022). Molecular epidemiological characteristics of carbapenem-resistant Klebsiella pneumoniae among children in China. AMB Express. 12 (1), 89.
Hu, H. (2023). Prevalence and molecular characteristics of colistin-resistant isolates among clinically isolated carbapenem-resistant Klebsiella pneumoniae in China. Int. J. Antimicrob. Agents. 62 (2), 106873.
Yang, Y. (2021). Molecular characterization of carbapenem-resistant and virulent plasmids in Klebsiella pneumoniae from patients with bloodstream infections in China. Emerg. Microbes Infect. 10 (1), 700–709.
Rees, C. A., Franchina, F. A., Nordick, K. V., Kim, P. J. & Hill, J. E. (2017). Expanding the Klebsiella pneumoniae volatile metabolome using advanced analytical instrumentation for the detection of novel metabolites. J. Appl. Microbiol. 122 (3), 785–795.
Ahmed, W. M. (2023). Microbial Volatiles as Diagnostic Biomarkers of Bacterial Lung Infection in Mechanically Ventilated Patients. Clin. Infect. Dis. 76 (6), 1059–1066.
Zhang, J. (2021). Breath volatile organic compound analysis: an emerging method for gastric cancer detection. J. Breath. Res. 15 (4), 1–24.
Lee, D. K. (2018). In Vitro Tracking of Intracellular Metabolism-Derived Cancer Volatiles via Isotope Labeling. ACS Cent. Sci. 4 (8), 1037–1044.
Chen, C., Wei, D., Shi, J., Wang, M. & Hao, J. (2014). Mechanism of 2,3-butanediol stereoisomer formation in Klebsiella pneumoniae. Appl. Microbiol. Biotechnol. 98 (10), 4603–4613.
Zahniser, M. P. (2017). Structure and mechanism of benzaldehyde dehydrogenase from Pseudomonas putida ATCC 12633, a member of the Class 3 aldehyde dehydrogenase superfamily. Protein Eng. Des. Sel. 30 (3), 271–278.
Bos, L. D., Sterk, P. J. & Schultz, M. J. (2013). Volatile metabolites of pathogens: a systematic review. PLoS Pathog. 9 (5), e1003311.
Pu, D., Zhao, J., Chang, K., Zhuo, X. & Cao, B. (2023). Superbugs with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China. Sci. Bull. (Beijing). 68 (21), 2658–2670.
Luterbach, C. L. (2023). Multi-Drug Resistant Organism Network Investigators Network I, the Antibacterial Resistance Leadership G. Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals. Clin. Infect. Dis. 76 (2), 229–237.
Kempf, M. (2012). Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry. PLoS One. 7 (2), e31676.
Knox, J. (2014). Phenotypic detection of carbapenemase-producing Enterobacteriaceae by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and the Carba NP test. J. Clin. Microbiol. 52 (11), 4075–4077.
Saerens, S. M. G., Delvaux, F. R., Verstrepen, K. J., and Thevelein, J. M. (2010). Production and biological function of volatile esters in Saccharomyces cerevisiae. Microb. Biotechnol. 3, 165–177.
Schnabel, R., Fijten, R., Smolinska, A., Dallinga, J., Schooten, F. J., Stobberingh, E., et al. (2015). Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia. Sci. Rep. 5, 17179.–10.
Seiflein, T. A., and Lawrence, J. G. (2006). Two transsulfurylation pathways in Klebsiella pneumoniae. J. Bacteriol. 188, 5762–5774.
Storer, M. K., Hibbard-Melles, K., Davis, B., and Scotter, J. (2011). Detection of volatile compounds produced bymicrobialgrowth in urinebyselectedion flowtube mass spectrometry (SIFT-MS). J. Microbiol. Methods 87, 111–113.
Tait, E., Perry, J. D., Stanforth, S. P., and Dean, J. R. (2014). Identification of volatile organic compounds produced by bacteria using HS-SPME-GC-MS. J. Chromatogr. Sci. 52, 363–373.
Whiteson, K. L., Meinardi, S., Lim, Y. W., Schmieder, R., Maughan, H., Quinn, R., et al. (2014). Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2, 3-butanedione fermentation. ISME J. 8, 1247–1258.
Xie, X., Lyu, J., Hussain, T., and Li, M. (2019). Drug prevention and control of ventilator-associated pneumonia. Front. Pharmacol. 10, 298–299.
Zahniser, M. P. D., Prasad, S., Kneen, M. M., Kreinbring, C. A., Petsko, G. A., Ringe, D., et al. (2017). Structure and mechanism of benzaldehyde dehydrogenase from Pseudomonas putida ATCC 12633, a member of the Class 3 aldehyde dehydrogenase superfamily. Protein Eng. Des. Sel. 30, 271–278.
Zechman, J. M., Aldinger, S., and Labows, J. N. (1986). Characterization of pathogenic bacteria by automated headspace concentration-gas chromatography. J. Chromatogr. 377, 49–57.
Zhu, M.,Xu,X.E., Li,Y., Wang,P., Niu, S., Zhang,K., et al. (2019). Biosynthesis of the nematode attractant 2-Heptanone and its co-evolution between the pathogenic bacterium bacillus nematocidaand non-pathogenic bacterium bacillus subtilis. Front. Microbiol. 10, 1489–1511.
Holt, K. E. et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc. Natl. Acad. Sci. U S A. 112 (27), E3574–3581.
Ahmed, W. M., Lawal, O., Nijsen, T. M., Goodacre, R. & Fowler, S. J. (2017). Exhaled Volatile Organic Compounds of Infection: A Systematic Review. ACS Infect. Dis. 3 (10), 695–710.
Foschi, C. (2018). Impact of meropenem on Klebsiella pneumoniae metabolism. PLoS One. 13 (11), e0207478.
Rees, C. A. (2018). Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profiles. Sci. Rep. 8 (1), 13297.
Yip, A. Y. (2023). Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites. Nat. Commun. 14 (1), 5094.
Brennan-Krohn, T., Manetsch, R., O’Doherty, G. A. & Kirby, J. E. (2020). New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae. Transl Res. 220, 14–3
Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.